Description
| Product Name | CAT.No | Details |
| Total Galactose | BXC0812A | 100T |
Product Description
The Biorex Diagnostics Total Galactose Kit is a high-quality neonatal screening assay designed for the early detection of galactosemia, a rare but serious metabolic disorder. This assay provides a simple, reliable, and sensitive method for measuring total galactose levels in newborns, enabling timely diagnosis and early dietary intervention to prevent complications such as liver damage, developmental delays, or other metabolic disturbances. Ideal for clinical laboratories, hospitals, and large-scale newborn screening programmes, the kit is specifically optimised for neonatal testing and high-throughput laboratory workflows.
Key Features
- Neonatal-Focused: Compatible with heel-prick dried blood spots, allowing minimally invasive sampling and reduced stress for newborns.
- Quantitative Measurement: Accurately determines elevated galactose levels, providing precise identification of infants at risk for galactosemia.
- Rapid and Reliable Results: Delivers fast, reproducible measurements to support timely clinical decision-making and early intervention.
- High Sensitivity and Specificity: Ensures accurate detection with minimal false positives or negatives, improving confidence in screening results.
- User-Friendly Workflow: Simple, streamlined procedures allow laboratory staff to perform the test efficiently, even in high-volume screening settings.
- Scalable for High Throughput: Suitable for hospitals and large-scale neonatal screening programmes, enabling simultaneous testing of multiple samples.
- Cost-Effective: Provides accurate neonatal screening at an economical price, reducing operational costs without compromising quality.
Benefits
The Biorex Total Galactose Kit delivers a reliable and clinically relevant solution for neonatal screening, combining precision, sensitivity, and ease of use. By enabling early detection of galactosemia, the assay allows healthcare providers to implement dietary interventions quickly, preventing serious complications and supporting optimal long-term health outcomes. Its ready-to-use reagents, robust methodology, and scalable workflow make it a trusted choice for laboratories seeking efficient, high-throughput, and accurate neonatal screening solutions.
With its combination of accuracy, reliability, and operational efficiency, the Biorex Total Galactose Kit ensures that at-risk infants are identified promptly and that laboratory teams can maintain high standards of patient care and clinical testing.
Contact Us for more information.